CHALAKUDY RAMAKRISHNA: Open Payments
NPI 1295790442 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,875 in 125 payments from 14 companies in 2025. Trend: 2023 $1,956 · 2024 $1,750 · 2025 $2,875
Food & beverage: $2,875
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 34 | $949 |
| Otsuka America Pharmaceutical, Inc. | 16 | $284 |
| Axsome Therapeutics, Inc. | 12 | $268 |
| ABBVIE INC. | 14 | $258 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $227 |
| Lundbeck LLC | 10 | $206 |
| Alkermes, Inc. | 6 | $142 |
| Validus Pharmaceuticals LLC | 5 | $115 |
| Teva Pharmaceuticals USA, Inc. | 4 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
Products named: HETLIOZ, REXULTI, Auvelity, VRAYLAR, FANAPT, CAPLYTA, ARISTADA, EQUETRO.
Industry payments across MI — which companies pay providers there.
